DDInter1757 DDInter1763
Telbivudine is a synthetic thymidine nucleoside analog with specific activity against the hepatitis B virus. Telbivudine is orally administered, with good tolerance, lack of toxicity and no dose-limiting side effects.
Temsirolimus is a derivative of sirolimus used in the treatment of renal cell carcinoma (RCC). It was developed by Wyeth Pharmaceuticals under the trade name Torisel. Temsirolimus was approved by the FDA in late May 2007 as well as the European Medicines Agency (EMEA) on November 2007.
Telbivudine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sirolimus
Sirolimus {u} (Compound) resembles {v} (Compound) Temsirolimus
Telbivudine {u} (Compound) causes {v} (Side Effect) Gastritis
Gastritis {u} (Side Effect) is caused by {v} (Compound) Temsirolimus
Telbivudine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sirolimus
Sirolimus {u} (Compound) resembles {v} (Compound) Everolimus
Everolimus {u} (Compound) resembles {v} (Compound) Temsirolimus
Telbivudine {u} (Compound) causes {v} (Side Effect) Gastritis
Gastritis {u} (Side Effect) is caused by {v} (Compound) Everolimus
Everolimus {u} (Compound) resembles {v} (Compound) Temsirolimus
Telbivudine {u} (Compound) resembles {v} (Compound) Trifluridine
Trifluridine {u} (Compound) upregulates {v} (Gene) LRP10
LRP10 {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Telbivudine {u} (Compound) resembles {v} (Compound) Decitabine
Decitabine {u} (Compound) binds {v} (Gene) DNMT3A
DNMT3A {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Telbivudine {u} (Compound) resembles {v} (Compound) Decitabine
Decitabine {u} (Compound) upregulates {v} (Gene) KIAA0355
KIAA0355 {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Telbivudine {u} (Compound) resembles {v} (Compound) Trifluridine
Trifluridine {u} (Compound) downregulates {v} (Gene) KAT6B
KAT6B {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Telbivudine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sirolimus
Sirolimus {u} (Compound) binds {v} (Gene) CYP3A4
CYP3A4 {u} (Gene) is bound by {v} (Compound) Temsirolimus
Telbivudine {u} (Compound) resembles {v} (Compound) Zidovudine
Zidovudine {u} (Compound) binds {v} (Gene) CYP3A4
CYP3A4 {u} (Gene) is bound by {v} (Compound) Temsirolimus
Telbivudine may cause a moderate interaction that could exacerbate diseases when taken with Sirolimus and Sirolimus (Compound) resembles Temsirolimus (Compound)
Telbivudine (Compound) causes Gastritis (Side Effect) and Gastritis (Side Effect) is caused by Temsirolimus (Compound)
Telbivudine may cause a moderate interaction that could exacerbate diseases when taken with Sirolimus and Sirolimus (Compound) resembles Everolimus (Compound) and Everolimus (Compound) resembles Temsirolimus (Compound)
Telbivudine (Compound) causes Gastritis (Side Effect) and Gastritis (Side Effect) is caused by Everolimus (Compound) and Everolimus (Compound) resembles Temsirolimus (Compound)
Telbivudine (Compound) resembles Trifluridine (Compound) and Trifluridine (Compound) upregulates LRP10 (Gene) and LRP10 (Gene) is upregulated by Temsirolimus (Compound)
Telbivudine (Compound) resembles Decitabine (Compound) and Decitabine (Compound) binds DNMT3A (Gene) and DNMT3A (Gene) is upregulated by Temsirolimus (Compound)
Telbivudine (Compound) resembles Decitabine (Compound) and Decitabine (Compound) upregulates KIAA0355 (Gene) and KIAA0355 (Gene) is upregulated by Temsirolimus (Compound)
Telbivudine (Compound) resembles Trifluridine (Compound) and Trifluridine (Compound) downregulates KAT6B (Gene) and KAT6B (Gene) is upregulated by Temsirolimus (Compound)
Telbivudine may cause a moderate interaction that could exacerbate diseases when taken with Sirolimus and Sirolimus (Compound) binds CYP3A4 (Gene) and CYP3A4 (Gene) is bound by Temsirolimus (Compound)
Telbivudine (Compound) resembles Zidovudine (Compound) and Zidovudine (Compound) binds CYP3A4 (Gene) and CYP3A4 (Gene) is bound by Temsirolimus (Compound)